Evidence map›Paper›PMID 27833915›Full record

ArticleBioMed research international2016

Exposure to

Nallely A Torres-Avilés, Damaris Albores-García, Ana L Luna, Monica Moreno-Galván, Mariana Salgado-Bustamante, Diana Patricia Portales-Pérez, Emma S Calderón-Aranda

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nallely A Torres-AvilésDepartamento de Toxicología, Centro de Investigación y Estudios Avanzados, IPN, Ciudad de México, Mexico.
Damaris Albores-GarcíaDepartamento de Toxicología, Centro de Investigación y Estudios Avanzados, IPN, Ciudad de México, Mexico.
Ana L LunaDepartamento de Toxicología, Centro de Investigación y Estudios Avanzados, IPN, Ciudad de México, Mexico; PIBIOM, ENMH, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Monica Moreno-GalvánHospital Infantil de México Federico Gómez, SSA, Ciudad de México, Mexico.
Mariana Salgado-BustamanteDepartamento de Bioquímica, Facultad de Medicina, UASLP, San Luis Potosí, SLP, Mexico.
Diana Patricia Portales-PérezLaboratorio de Inmunología Celular y Molecular, Facultad de Ciencia Químicas, UASLP, San Luis Potosí, SLP, Mexico.
Emma S Calderón-ArandaDepartamento de Toxicología, Centro de Investigación y Estudios Avanzados, IPN, Ciudad de México, Mexico.ORCID 0000-0001-8284-2217
Instituto Politécnico Nacional · MXAutonomous University of San Luis Potosí · MXHospital Infantil de México Federico Gómez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dichlorodiphenyldichloroethylene (

Indexed as

Bone MarrowCalciumCCAAT-Enhancer-Binding Protein-betaCell DifferentiationCell LineDichlorodiphenyl DichloroethyleneHL-60 CellsHumansMAP Kinase Signaling SystemMyeloid CellsOxidative StressProtein Kinase C-alphaCalciumCCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanDichlorodiphenyl DichloroethyleneProtein Kinase C-alpha

Identifiers

PMID27833915
PMCPMC5090076
OpenAlexW2536985777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.